Administration of chondroprotector piascledine in the treatment of secondary osteoarthritis in patients with gout
Objective. To study clinical efficacy and safety of piascledine in the treatment of osteoarthritis (OA) in pts with gout.Material and methods. 30 pts older than 35 years with gout and concomitant OA were included. During 2 months they received piascledine 300 mg/day. All pts fulfilled Wallace S. cri...
| المؤلفون الرئيسيون: | , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | Russian |
| منشور في: |
IMA PRESS LLC
2016-05-01
|
| سلاسل: | Научно-практическая ревматология |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://rsp.mediar-press.net/rsp/article/view/2190 |